C12N2770/20044

VACCINES AGAINST CORONAVIRUS AND METHODS OF USE
20250121054 · 2025-04-17 ·

Disclosed herein are nucleic acid molecules encoding a SARS-CoV-2 spike antigen. SARS-CoV-2 spike antigens, immunogenic compositions, and vaccines and their use in inducing immune responses and protecting against or treating a Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) infection in a subject.